NCT05001243View on ClinicalTrials.gov

Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients

PHASE1UnknownINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 10, 2021

Primary Completion Date

August 30, 2021

Study Completion Date

September 10, 2021

Conditions
Presbyopia
Interventions
DRUG

Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac

PBOHB to improve uncorrected near vision in healthy presbyopic patients

DRUG

Pilocarpine Hydrochloride

Apply in the fellow eye

DRUG

Brimonidine Tartrate

Apply in the fellow eye

Trial Locations (1)

01090

RECRUITING

Optall Vision, Mexico City

Sponsors

Lead Sponsor

Optall Vision
All Listed Sponsors
lead

Optall Vision

OTHER

NCT05001243 - Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients | Biotech Hunter | Biotech Hunter